Ousted vaccine director and whistleblower Rick Bright testified for more than three hours before the House Committee on Energy and Commerce’s health subcommittee.
Bright slammed the Trump administration’s coronavirus response and urged lawmakers to listen to the voices of scientists to prevent “unprecedented illness and fatalities.”
If you’re just tuning in, here are four key points Bright made in his testimony today:
Rick Bright said that there still aren’t enough coronavirus tests when pressed about miscommunication from the Trump administration by Michigan Rep. Debbie Dingell.
Rep. Dingell: “So, even this week, as we’re being told, ‘Anybody who wants a test, can have a test,’ is that true in the United States of America?”
Bright: No.
President Trump has repeatedly stated that the anyone who wants a test can get one, despite experts saying otherwise.
Bright also said that it is “unlikely” that a vaccine for the coronavirus will be available within the next few months.
Watch the full exchange:
Rick Bright told lawmakers that he will turn over documents to Congress related to his whistleblower complaint following his testimony before the House Energy and Commerce health subcommittee.
He confirmed to subcommittee Chair Anna Eshoo that once personal information is removed from his documents, he will make them available to the committee. Eshoo added that, per normal protocol, the documents would be shared with both majority and minority members of the committee.
Bright’s comments came after Rep. Greg Walden, a Republican from Oregon, repeatedly asked Bright and his counsel to turn over documents related to Bright’s whistleblower complaint.
“We have partial email chains, we have screenshots of emails. I think we should have the right to see those documents if we’re going to effectively know the full extent of this complaint,” Walden said.
Walden later pleaded with Eshoo: “Madam Chair you should request them.”
“We will seek all information that’s appropriate to be submitted to the committee. And what I circulated or we circulated to all members of the subcommittee were the emails that were public, as well as the complaint,” Eshoo answered.
“But in any other, you know, any other investigation we’d both be going say we need to see all the documents as a committee, so that’s all I’m after,” Walden responded.
Rep. Markwayne Mullin, a Republican from Oklahoma, grilled ousted vaccine director Rick Bright on his current job position, and questioned why he needs medical leave for his hypertension now, although he did not have issues with hypertension while he served as director of the Biomedical Advanced Research and Development Authority (BARDA).
Mullin also questioned which department is currently paying Bright’s salary.
Here’s the exchange:
Mullin: “But if you’ve been on medical leave you are too sick to do that but you can prepare for a two hour hearing. I am having a hard time tracking it and understanding it. If you have hypertension and you are too sick to go to NIH but you did not experience that at Barta, right? You never had issues in Barta with hypertension?”
Bright: “I didn’t have the level of stress from being removed from my position. This has been very stressful.”
Mullin: “I get that people handle pressure differently. You are in quite a stressful position when you are trying to manage pandemic but you can’t manage that, well you could manage that, but you can’t manage your own hypertension because you got removed from the office but yet you can still receiving pay from NIH, but you can’t show up for work, and then also you can prepare for this but you can’t do that.”
Bright later confirmed to subcommittee Chairwoman Anna Eshoo that he is on accrued vacation leave today.
Some context: HHS issued a statement today saying in part, “Mr. Bright has not yet shown up for work, but continues to collect his $285,010 salary, while using his taxpayer-funded medical leave to work with partisan attorneys who are politicizing the response to COVID-19.”
Ousted vaccine director Rick Bright urged House members to make sure science — not politics — takes precedence in the US coronavirus response.
“We need to unleash the voices of the scientists in our public health system in the United States so they can be heard and their guidances need to be listened to,” Bright said.
Bright also noted that the information of scientists must be conveyed to the America public so “they have the truth about the real risk and dire consequences of this virus.”
Bright, now a senior advisor with the National Institutes of Health, said he was forced out of his Biomedical Advanced Research and Development Authority job last month for political reasons.
Watch:
The Trump administration rushed out recommendations about the drug hydroxychloroquine to treat coronavirus, Rick Bright, the ousted director of Biomedical Advanced Research and Development Authority, said during today’s hearing.
Asked about attempts to rely on politics rather than science in the response to the pandemic, Bright said: “There were some attempts to bypass that rigorous vetting process that caused me great concern.”
Speaking to the House Energy and Commerce Committee hearing, Bright said, “We have a very rigorous scientific review process for all the investments that we make for the drugs, vaccines and diagnostics through BARDA and through our department.”
Bright said “without that scientific vetting, that does increase the risk of a drug being evaluated or supported, that could have safety concerns. And we really needed to have the best scientists in our country weigh in on whether or not that drug should be evaluated and how it should be evaluated to address those safety concerns.”
Remember: Last week, Bright filed a whistleblower complaint alleging he was removed from his post in retaliation for opposing the broad use of hydroxychloroquine.
Rick Bright said he began to get alerts that the supply chain for masks and other personal protective equipment was “diminishing rapidly” back in January. But when he forwarded the alerts to leadership in the US Department of Health and Human Services, as well as with national infrastructure and stockpile teams, he said they were ignored.
“I was met with indifference, saying they were either too busy, they didn’t have a plan, they didn’t know who was responsible for procuring those. … A number of excuses. But never any action,” he said in his testimony.
Bright said that in a meeting on Feb. 7, HHS leadership said they did not believe there would be a shortage of N95 masks. “My response was, ‘I cannot believe you can sit and say that with a straight face.’ It was absurd,” he said.
The supply shortages caused needless deaths, according to Bright, and continue to put health care workers in harm’s way.
He said experts have known since 2007 that the US would have a shortage of respirators in case of a pandemic.
Watch:
Rick Bright said there appears to be “no master coordinated plan” on how the US is responding to coronavirus.
Rep. G. K. Butterfield asked Rick Bright about the US’s supply shortages, which has included a lack of simple supplies like swabs.
“How could we be struggling to get adequate supplies of simple supplies like swabs? What does this say about the federal response to the coronavirus outbreak?” Butterfield asked.
Here’s how Bright responded:
Watch:
Rick Bright told House members that the lack of a plan and strategy in the US on how to make and administer a potential vaccine for coronavirus is a “significant concern.”
“We don’t have that yet and it is a significant concern,” he said.
When asked by Rep. Frank Pallone if Bright thought the supply issues the US has seen with testing and the drug remdesivir could also happen with vaccines, the doctor answered, “Absolutely, sir.”
Watch:
The Trump Administration is already pushing back hard against claims made by Rick Bright, the ousted director of a crucial federal office charged with developing countermeasures to infectious diseases.
Bright just testified that the US will face “unprecedented illness and fatalities” without additional preparations to curb the coronavirus pandemic.
White House Press Secretary Kayleigh McEnany provided the first on-camera reaction from the White House to Bright’s testimony, repeatedly stating that Bright wasn’t “paying attention.”
She continued, “Sounds like he wasn’t paying attention when he talked about building up a stockpile of equipment. Perhaps he’s unaware of the 90 million N95 respirators the President’s delivered — three times what the healthcare industry consumes in an average year, the billion gloves we’ve delivered, the many more pieces of PPE. It sounds like this is someone who’s reacting and making suggestions that have long been put into play.”
And earlier this morning, the Health and Human Service Department released a press release in their first big pushback against claims Bright made in his whistleblower complaint.
“His whistleblower complaint is filled with one-sided arguments and misinformation,” the press release reads. “HHS is reviewing the complaint and strongly disagrees with the allegations and characterizations made by Rick Bright.”
Rick Bright said he thinks his removal from the Biomedical Advanced Research and Development Authority was due to his opposition to using the drug chloroquine in coronavirus patients.
Bright said there wasn’t sufficient data supporting the drug, which was widely touted by President Trump, and that there was possibility of adverse and even deadly side effects.
“When I spoke with the government and shared my concerns for the American public, that, I believe, was the straw that broke the camel’s back and escalated my removal,” he said in his testimony.
Watch:
When asked about a timeline for the creation of a vaccine, Rick Bright called the timeline of 12 to 18 months an “aggressive schedule.”
“A lot of optimism is swirling around a 12- to 18-month time frame. If everything goes perfectly — we’ve never seen everything go perfectly,” Bright said.
Earlier in the hearing, Bright noted that “multiple shots” need to be taken to create a vaccine.
“There are many diseases we’ve attempted to make vaccines for in history and we still haven’t been able to do so. It takes many opportunities and many different approaches,” Bright said.
When asked by Rep. Eshoo about what could be done for the country “to get it right” on coronavirus response, Bright noted that a “comprehensive strategy” was needed that included widespread testing, tracing and ongoing efforts to “develop a cure.”
Bright said the Trump administration’s preparation for the pandemic was lacking and “critical steps” were not taken in time.
“The window is closing to address this pandemic because we still do not have a standard centralized coordinated plan to take this nation through this response,” Bright said.
In his opening remarks, ousted vaccine director Rick Bright told House members that “Americans deserve the truth,” and he said scientists must be allowed to “speak without fear of retribution.”
In his filed a whistleblower complaint last week, Bright alleged he was removed from his post in retaliation for opposing the broad use of a drug frequently touted by President Trump as a coronavirus treatment.
Rick Bright, who once lead the federal office charged with developing countermeasures to infectious diseases, said the US will endure “darkest winter in modern history” if the US does not take extra preparations for coronavirus.
Bright was recently removed from his post at Biomedical Advanced Research and Development Authority. He has said he was removed and transferred to “a more limited and less impactful position” at National Institutes of Health after he “resisted efforts to promote” the “unproven” drug hydroxychloroquine.
Watch:
Rep. Michael Burgess, the Republican ranking member of the House’s health subcommittee, noted that whistleblower Rick Bright “raised serious allegations” in his complaint.
However, Burgess called Bright’s hearing “premature” and said it was a “disservice” to investigations into Bright’s complaint.
Burgess also slammed his Democratic colleagues for what he alleged was a delayed participation in the coronavirus pandemic debate.
“We should be conducting a hearing on the real time implementation of the pandemic all hazardous preparedness in advance reservation act. And we should have done it in February.” Burgess said.
About the complaint: Bright, who once served as the director of a key federal office charged with developing medical countermeasures, said he filed a whistleblower complaint last week alleging he was removed from his post in retaliation for opposing the broad use of a drug frequently touted by President Trump as a coronavirus treatment.
Watch:
Chair Anna Eshoo, a Democrat from California, at today’s House Energy and Commerce health subcommittee criticized the Trump administration.
She called Rick Bright’s whistleblower filing “one of the most specific and troubling whistleblower complaints I’ve ever seen.”
Some background: Bright was recently removed from his post at Biomedical Advanced Research and Development Authority. He has said he was removed and transferred to “a more limited and less impactful position” at National Institutes of Health after he “resisted efforts to promote” the “unproven” drug chloroquine.
Rep. Anna Eshoo, the chair of the House’s Health subcommittee, kicked off today’s hearing by slamming the Trump administration’s response to the coronavirus pandemic.
Eshoo called the White House’s response an “inept, ineffective and extremely late effort” and said the government has failed the more than “80,000 souls that have been lost.”
Watch:
Rep. Anna Eshoo, the chair of the health subcommittee of the House’s Committee on Energy and Commerce, paused during her opening statement for a moment of silence to honor the victims of cortonavirus.
The health subcommittee of the House’s Committee on Energy and Commerce is in session to hear the testimony of Rick Bright, the ousted director of the office involved in developing a coronavirus vaccine.
Bright is wearing a mask, as are some of the House members.
Lawmakers are seated far apart from each other inside the hearing room.
